UK markets open in 5 hours 17 minutes
NIKKEI 225
38,910.37 +293.27 (+0.76%) HANG SENG
19,024.41 -171.19 (-0.89%) CRUDE OIL
76.86 -0.71 (-0.92%) GOLD FUTURES
2,369.60 -23.30 (-0.97%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,646.95 -435.37 (-0.79%)
MGNX May 2024 20.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:48AM EDT. Market open.
Loading interactive chart…
- GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will parti
- Simply Wall St.
US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
As you might know, MacroGenics, Inc. ( NASDAQ:MGNX ) last week released its latest first-quarter, and things did not...
- GuruFocus.com
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
Insight into Macrogenics' Financial Health and Future Clinical Prospects
© 2024 Yahoo. All rights reserved.